Recent reports on the chromosomes and total DNA of the chicken cell nucleus show that they differ from those of typical placental mammals in an unusual pattern of chromosome sizes and a DNA content equal to half of that of most mammals … anomalies include incomplete dominance … and alteration of phenotypic sex without visible alterations in the karyotype. One explanation … could be that three-fourths of the normal genetic dose occurs fairly frequently in the chicken. Three-fourths of the normal gene dose could occur if each of the arms of the major chromosomes in the chicken were isochromosomes … which double back on themselves for transcription but straighten out and are apposed in the orthodox manner for meiosis … A chromosome pair would provide four readings of the message, and a cell with three out of four of the normal readings might well be viable … One evolutionary advantage of the looped isochromosome system proposed here might be that such a chromosome would be better able to withstand the damage to the DNA … caused by the relatively high internal temperature of birds. From Nature 12 November 1966
Years Ago
In Nature of October 5 it is stated that the cause of the optical deterioration of the atmosphere in July and August "is for the time being still in doubt. Up to the present no reports of volcanic eruptions have come to hand from any part of the globe. " I wish to state that in July a strong outburst occurred of the Stromboli volcano … there was an extraordinary eruption of fluid and incandescent lava to a great height, followed by a thick rain of lapilli and ashes. From Nature 9 November 1916 ), and suggest that this is driven by a combination of environmental and anthropogenic factors. The results show that a careful analysis of long-term coastal records can uncover more-recent changes, which will help in developing predictive models. Ryan Wilkinson
GEOSCIENCE

Cliffs make a hasty retreat
utations in blood stem cells can result in excessive production of one or more types of mature blood cell and a form of cancer called a myeloproliferative neoplasm. One such neoplasm is juvenile myelo monocytic leukaemia (JMML), a rare childhood disease characterized by expansion of the white blood cell population 1 . Currently, JMML can be treated only by stem-cell transplantation, but about 50% of patients relapse following this procedure. A more detailed understanding of the disease could lead to new therapies and improved outcomes. Dong et al. 2 report on page 304 that mutation of the gene Ptpn11 in the non-blood cells that surround blood stem cells causes a JMML-like cancer in mice, owing to altered interactions between these two cell types.
Mutations in genes that encode proteins of the RAS-ERK signalling pathway are found in the blood cells (but no other cells) of about 90% of children with sporadic JMML (refs 1, 3) . The most frequent of these occur in the gene PTPN11 (refs 1, 3) . Such mutations activate
CANCER
Bad neighbours cause bad blood
Expression of a blood-cancer-associated genetic mutation in the non-blood cells of the bone marrow is sufficient to cause blood cancer in mice. This finding could point to new approaches to treating an often-fatal disease. See Letter p.304 the enzyme encoded by PTPN11, called SHP2, increasing RAS-ERK signalling. Certain PTPN11 mutations can be inherited and so are present in all cells of the body -this leads to the developmental disorder Noonan syndrome 4 . This syndrome is characterized by cardiac, facial, cognitive and growth abnormalities, but about 20% of affected children also have abnormal white blood cell counts, and a few develop a congenital form of JMML.
Previous studies of JMML have focused on the effects of disease-associated PTPN11 in blood cells, and have established that expression of the mutant gene in these cells alone can promote development of a JMML-like myeloproliferative neoplasm (MPN) in mice 5, 6 . Dong et al. confirmed that blood-cell-restricted expression of mutant Ptpn11 causes MPN (Fig. 1a) . They next studied mice that harbour Ptpn11 mutations only in stromal (non-blood) cell types of the b one marrow, which surround the developing blood cells. Surprisingly, these mice, which have genetically normal blood cells, develop a disease similar to congenital JMML, in which the mutant gene is present in all tissues.
The authors report that mutant Ptpn11 can give rise to MPN when expressed in some stromal cells of the bone marrow (mesenchymal stem cells and the bone progenitors that they give rise to), but not in others (mature bone or blood-vessel cells). Furthermore, if genetically normal blood stem cells reside long enough in this abnormal microenvironment, they become fully cancerous and can give rise to MPN when transplanted into healthy mice. Presumably, the microenvironment induces genetic mutations or epi genetic changes -modifications that affect gene expression without changing DNA sequence -in normal blood stem cells that result in this transformation.
What these changes in normal blood stem cells are, and whether they affect genes of the RAS-ERK pathway, is a question left un resolved. Perhaps clarifying this issue would shed light on the causes of the approximately 5-10% of JMML cases for which a genetic basis is undefined 1 . For example, might these cancers be caused by mutations in mesenchymal stem cells, rather than blood stem cells?
The finding that an abnormal bone-marrow microenvironment can promote blood disease is not unprecedented: a variety of genetic alterations can evoke MPN or acute leukaemia when engineered into the bone-marrow stromal cells of mice 7 . But Dong and colleagues model an actual human disease -JMML associated with Noonan syndrome -in which an aberrant bone-marrow microenvironment is present from birth. Their results therefore suggest that such a microenvironment might provide the initial, and potentially the more potent, MPNpromoting stimulus in congenital JMML.
The levels of SHP2 activation caused by PTPN11 mutation in patients can vary 1, 3 . Only the most strongly activating mutations cause JMML in children with Noonan syndrome. Perhaps, under such circumstances, JMML can develop only when both blood cells and the stromal microenvironment bear the mutant gene. A similar requirement has been reported for a mouse model of MPN caused by another genetic defect 8 . Dong et al. find that several pro-inflammatory factors produced by mutant stromal cells, including the protein CCL3, are present in blood serum from stromal-cell-specific Ptpn11 mutant mice and from people with Noonan syndrome. These findings suggest that such factors could serve as biomarkers to identify children at increased risk of JMML. Furthermore, the authors find that drugs that block CCL3 action reduce the incidence of MPN in mice (Fig. 1b) . Admini stering such drugs to high-risk patients might spare them from requiring stem-cell transplantation.
The current study also has potential implications for sporadic JMML. Previous studies showed that aberrant blood cells can send signals to stromal cells that alter the bone-marrow microenvironment to favour the blood cells' own expansion or to impede the survival, proliferation and function of normal blood stem cells 7 . Dong et al. find that, like the mutant stroma, Ptpn11 mutant blood cells produce pro-inflammatory factors. This suggests a vicious circle in which mutant blood cells perturb the microenvironment, which in turn augments expansion of the cancerous bloodcell population. If bone-marrow stromal cells have been rendered abnormal by cancerous blood cells in sporadic JMML, persistence of this abnormal microenvironment might contribute to disease recurrence after a stem-cell transplant.
Consequently, perhaps the most immediate intervention suggested by Dong and colleagues' work is to investigate the effects of CCL3 blockers in transplant regimens for children with JMML. One such drug, maraviroc, is already used to treat HIV, and also blocks graft-versus-host disease -a complication of bone-marrow transplantation 9 . The authors find that such agents are more effective at preventing MPN post-transplant than in combating established MPN in mice. Nevertheless, combining these blockers with targeted therapies aimed at reversing the effects of increased RAS-ERK activation could represent a promising therapeutic strategy for JMML.
Finally, the results of the current study resonate with, and inform, emerging themes in cancer biology. It is becoming clear that the interactions between cancerous cells and their microenvironment determine cancer behaviour and response to therapy. It is also known that inflammation can initiate, as well as enhance, cancer. In solid tumours, one major effect of tumour-associated inflammation is to suppress the host immune system 10 . It will be interesting to see whether therapies directed against the JMML microenvironment evoke or augment an anti-MPN immune response. ■ 
Gordon Chan is in the Leslie
G E O R G E F I N K
M odern research into biological stress -the physiological response of an organism to stressful stimuli -spans broad disciplines, from genetics to endocrinology to brain imaging. Much of this diverse field has a shared origin in a landmark paper published 80 years ago in Nature
In this brief note, the biologist Hans Selye described a common physiological response in rats subjected to a diverse range of harmful factors; he named this the stress response 2 . Selye's observation set the scene for decades of future discoveries.
The history of stress research begins in the mid-nineteenth century with the physiologist Claude Bernard 3 , who proposed that the cells of the body are bathed in a fixed internal environment that is maintained in the face of changing external conditions by compensatory physiological changes. In the early twentieth century, this concept was termed homeo stasis by another physiologist, Walter Cannon 4 . Cannon described how animals react to stimuli that threaten homeostasis with a physiological response that he dubbed 'fight or flight' .
In his 1936 paper, Selye reported that when rats were subjected to nonspecific damaging agents such as exposure to cold, surgical injury or intoxication with diverse drugs, they showed a typical response that was not dependent on the nature of the agent. He described three phases to this general adaptation syndrome (GAS): alarm, resistance and exhaustion. Alarm corresponds to the fight-or-flight response described by Cannon; resistance to a period in which the body adapts to repeated exposure to the stress; and exhaustion to a relapse of symptoms that occurs if the stress is exerted for too long. The main features of the syndrome were suppression of the immune system, ulceration of the lining of the stomach and small intestine, and activation of the two main neuronally activated stress-response systems -the hypothalamic-pituitary-adrenocortical (HPA) axis and the sympathomedullary system (Fig. 1) .
In the HPA axis, activation of nerves in the brain's hypothalamus triggers release of the hormone corticotropin-releasing factor (CRF), which in turn causes secretion of the hormone adrenocorticotropin (ACTH) from the pituitary gland at the base of the brain into the blood. ACTH stimulates secretion of hormones, including cortisol, from the cortex of the adrenal gland. Hypothalamic signalling also triggers the sympathomedullary system, which increases heart rate, shunts blood from the skin and gut towards the skeletal muscles, and releases adrenaline from the medulla region of the adrenal gland. Adrenaline and cortisol act synergistically to increase levels of glucose in the blood 5 , providing the energy required for fight or flight.
Selye defined stress as "the nonspecific response of the body to any demand" 2, 6, 7 . He believed that stress was different from emotional arousal or nervous tension 6 because, as he wrote, the same general response was known to occur under or in response to anaesthesia in humans and animals, and also to occur in plants and bacteria, which have no nervous system (the generality of this response is reviewed in refs 8 and 9). Thus, he concluded, stress has a key protective role in all organisms. Moreover, he correctly proposed that the stress response is the same whether a stimulus is pleasant or unpleasant -the key factor is whether the intensity of the stimulus necessitates adaptation 7 . The biologist's views and definition of stress were widely accepted, although not without resistance 6, 10 . In fact, recognition of the fact that stress is not necessarily due to nervous
In Retrospect
Eighty years of stress
The discovery in 1936 that rats respond to various damaging stimuli with a general response that involves alarm, resistance and exhaustion launched the discipline of stress research. The syndrome involves three phases: alarm, resistance and exhaustion (ARE). Release of the hormone adrenocorticotropin (ACTH) in response to stress stimulates secretion of multiple hormones from the adrenal gland, affecting many organs and systems, including the thymus glands and stomach (pictured). NEWS & VIEWS RESEARCH
